Ala. High Court To Reconsider Landmark Generic-Drug Ruling
The Alabama Supreme Court agreed Thursday to reconsider its January ruling that makers of brand-name drugs can be held liable for injuries caused by their generic counterparts, after Pfizer Inc. and...To view the full article, register now.
Already a subscriber? Click here to view full article